Biologicals Is The Future In Thermo Fisher: Buy Rating

Company Performance - Thermo Fisher Scientific (NYSE: TMO) stock has shown little growth for its shareholders since August 2021 [1] - The company is expected to potentially reverse this trend and begin seeing growth again by 2025 [1] Analyst Perspective - The analyst specializes in financials, consumer, and technology industries with over seven years of experience [1] - The analyst prioritizes deep research into business model trends to understand future company perspectives rather than focusing on short-term market trends or stock prices [1] - This research approach is considered valuable for identifying long-term growth investment opportunities while avoiding risky financial instruments [1] Disclosure - The analyst has no current stock, option, or derivative positions in the mentioned companies but may initiate a long position in TMO within the next 72 hours [2] - The article represents the analyst's personal opinions and is not influenced by compensation or business relationships with the mentioned companies [2]